-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on RXO, Lowers Price Target to $23

Benzinga·08/07/2026 20:05:19
Listen to the news
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.